期刊文献+

黑曲霉孢子悬液贮存期的验证 被引量:4

The Verification of Aspergillus niger Spore Suspension's Storage Period
在线阅读 下载PDF
导出
摘要 目的:对贮存期的黑曲霉孢子悬液的质量进行考察和研究。方法:采用计数法及药敏实验对黑曲霉孢子悬液在贮存期的变化进行分析。结果:低温(4℃)保存6个月内黑曲霉孢子悬液菌落计数结果稳定,药物敏感性未出现变化,符合药典的规定。结论:在实验中,验证过的储存期内黑曲霉孢子悬液可直接稀释使用。 Objective:To investigate and study the quality of Aspergillus niger spore suspension.Methods:By counting and susceptibility test to conduct the experiments.Results: The cryopreservation ( 4 ℃) of Aspergillus niger spore suspension within 6 months showed no significant changes in drug sensitivity and counting results of colonies were stable , conformed to the standard of Chinese Pharmacopeia.Conclusion:Aspergillus niger spore suspension can be diluted directly in the specific experiment during the the storage that was verified.
出处 《中国药品标准》 CAS 2014年第2期117-119,共3页 Drug Standards of China
关键词 黑曲霉 孢子悬液 贮存期验证 验证方法 Aspergillus niger spore suspension verification of the storage period verified method
作者简介 林吉恒,初级药师;研究方向:食品学。 通讯作者:胡昌勤,研究员;Tel:13910109199;E—mail:hucq@nicpbp.org.cn
  • 相关文献

参考文献7

二级参考文献28

  • 1Comet M, Fleury L, Maslo C, et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area[J]. J Hosp Infect, 2002, 51(4): 288-296.
  • 2Moore CB, Walls CM, Denning DW. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B [J]. Antimicrob Agents Chemother, 2001, 45(6): 1882-1885.
  • 3Nationakl Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of illamentous fungi; Approved Standards[S]. NCCLS document M38-A (ISBN 1-56238-470-8). Wayne, Pennsylvania, USA, 2002.
  • 4Mosquera J, Sharp A, Moore CB, et al. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5- flucytosine against Aspergillus spp [J]. J Antimicrob Chemother, 2002, 50(2): 189-194.
  • 5Hsueh PR, Lan YJ, Chuang YC, et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003 [J]. Antimicrob Agents Chemother, 2005, 49(2): 512-517.
  • 6Moore CB, Sayers N, Mosquera J, et al. Antifungal drug resistance in Aspergillus[J]. J Infect, 2000, 41(3):203-220.
  • 7Barchiesi F, Schimizzi AM, Caselti F, et al. Interactions between triazoles and amphotericin B against Cryptococcus neoformans[J]. Antimicrob Agents Chemother, 2000, 44(9): 2435-2441.
  • 8Barchiesi F, Schimizzi AM, Najvar LK, et al. Interactions of posaconazole and ftucytosine against Cryptococcus neoformans [J]. Antimicrob Agents Chemother, 2001, 45(5): 1355-1359.
  • 9Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species [J]. Med Mycol, 2001, 39(1): 91-95.
  • 10Te Dorsthorst DT, Verweij PE, Meis JF, et al. Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates[J]. Antimicrob Agents Chemother, 2002, 46(3): 702-707.

共引文献20

同被引文献77

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部